Antimicrobial Therapy During Pregnancy [terapêutica Antimicrobiana Durante A Gestação]

dc.creatorDel Fiol F.D.S.
dc.creatorGerenutti M.
dc.creatorGroppo F.C.
dc.date2007
dc.date2015-06-30T18:40:49Z
dc.date2015-11-26T14:31:30Z
dc.date2015-06-30T18:40:49Z
dc.date2015-11-26T14:31:30Z
dc.date.accessioned2018-03-28T21:34:52Z
dc.date.available2018-03-28T21:34:52Z
dc.identifier
dc.identifierRevista Brasileira De Medicina. , v. 64, n. 3, p. 111 - 119, 2007.
dc.identifier347264
dc.identifier
dc.identifierhttp://www.scopus.com/inward/record.url?eid=2-s2.0-34248524370&partnerID=40&md5=53e59b0fe9957484e1a91c0c354aef5b
dc.identifierhttp://www.repositorio.unicamp.br/handle/REPOSIP/104315
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/104315
dc.identifier2-s2.0-34248524370
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1247386
dc.descriptionLike anybody else, pregnant women are susceptible to infections. The correct treatment of these women, however, must consider along with pathogens, the infection site and antibiotic pharmacokinetics, the fetus and possible side effects to the child. When prescribing over this special condition, the physician must remember that the prescription will affect two people and the drug must treat the mother without affect the fetus. Beta-lactams having a long history of use without significant deleterious effects on the fetuses still are the safest choice during pregnancy. However, considering the constant increase of multi-resistant microorganisms, the physician has been forced to use some kind of different antimicrobial agent. Usually, data regarding safety during pregnancy are very limited on the "newer agents", which causes serious doubts during their prescription. In addition, many studies regarding the safety use of antibiotics during pregnancy are inconclusive or demand more evidences. The present study is a wide revision regarding the use of antibiotics during pregnancy, considering their pharmacokinetics and the clinical experience in recent years. © Copyright Moreira Jr. Editora.
dc.description64
dc.description3
dc.description111
dc.description119
dc.descriptionMantovani, A., Calamandrei, G., Delayed developmental effects following prenatal exposure to drugs (2001) Curr Pharm Des, 7, pp. 859-880
dc.descriptionMengue, S.S., Schenkel, E.P., Duncan, B.B., Schmidt, M., Drug use by pregnant women in six Brazilian cities (2001) Rev Saude Publica, 35, pp. 415-420
dc.descriptionGomes, K.R., Moron, A.F., Silva, R., Siqueira, A.A., Prevalence of use of medicines during pregnancy and its relationship to maternal factors (1999) Rev Saude Publica, 33, pp. 246-254
dc.descriptionRao, J.M., Arulappu, R., Drug use in pregnancy. How to avoid problems (1981) Drugs, 22, pp. 409-414
dc.descriptionChristensen, B., Which antibiotics are appropriate for treating bacteriuria in pregnancy? (2000) J Antimicrob Chemother, 46, pp. 29-34
dc.descriptionDashe, J.S., Gilstrap, L.C., Antibiotic use in pregnancy (1997) Obstet Gynecol Clin North Am, 24, pp. 617-629
dc.descriptionSa Del Fiol, F., Rocha, D., Mattos Filho, T., Groppo, F.C., Evaluation in an animai model and in vitro of the combination clavulanic acid and cephalosporins against beta-lactamase producing and nonproducing Staphylococcus aureus strains (2000) Braz J Infect Dis, 4, pp. 36-42
dc.descriptionLoebstein, R., Lalkin, A., Koren, G., Pharmacokinetic changes during pregnancy and their clinical relevance (1997) Clin Pharmacokinet, 33, pp. 328-343
dc.descriptionWeller, T.M.A., Rees, E.N., Antibacterial use in pregnancy (2000) Drug Saf, 22, pp. 335-338
dc.descriptionPhilipson, A., Stiernstedt, G., Ehrnebo, M., Comparison of the pharmacokinetics of cephradine and cefazolin in pregnant and non-pregnant women (1987) Clin Pharmacokinet, 12, pp. 136-144
dc.descriptionNiebyl, J.R., Antibiotics and other anti-infective agents in pregnancy and lactation (2003) Am J Perinatol, 20, pp. 405-414
dc.descriptionLoebstein, R., Koren, G., Clinical relevance of therapeutic drug monitoring during pregnancy (2002) Ther Drug Monit, 24, pp. 15-22
dc.descriptionBoobis, A.R., Lewis, P., Drugs in pregnancy. Altered pharmacokinetics (1982) Br J Hosp Med, 28, pp. 566-573
dc.descriptionBriggs, G.G., Freeman, R.K., Yaffe, S.J., (2002) Drugs in pregnancy and lactation, pp. 284-312. , 6th ed. Baltimore: Williams & Wilkins
dc.descriptionCzeizel, A.E., Rockenbauer, M., Sorensen, H.T., Olsen, J., A population-based case-control teratologic study of ampicillin treatment during pregnancy (2001) Am J Obstet Gynecol, 185, pp. 140-147
dc.descriptionBlanchard, M., Oppliger, R., Bucher, U., Positive direct Coombs' test in acute leukemias and other hemoblastoses: Relation to clavulanic acid-containing antibiotics? (1989) Schweiz Med Wochenschr, 119, pp. 39-45
dc.descriptionWilliams, M.E., Thomas, D., Harman, C.P., Mintz, P.D., Donowitz, G.R., Positive direct antiglobulin tests due to clavulanic acid (1985) Antimicrob Agents Chemother, 27, pp. 125-127
dc.descriptionCzeizel, A.E., Rockenbauer, M., Olsen, J., Use of antibiotics during pregnancy (1998) Eur J Obstet Gynecol Reprod Biol, 81, pp. 1-8
dc.descriptionFonseca, M.R.C.C., Fonseca, E., Bergsten-Mendes, G., Prevalence of drug use during pregnancy: A pharmacopepidemiological approach (2002) Rev Saude Publica, 36, pp. 205-212
dc.descriptionCzeizel, A.E., Rockenbauer, M., Olsen, J., Sorensen, H.T., Oral Phenoxymethylpenicillin treatment during pregnancy. Results of a population-based Hungarian case- control study (2000) Arch Gynecol Obstet, 263, pp. 178-181
dc.descriptionDencker, B.B., Larsen, H., Jensen, E.S., Schonheyder, H.C., Nielsen, G.L., Sorensen, H.T., Birth outcome of 1886 pregnancies after exposure to Phenoxymethylpenicillin in utero (2002) Clin Microbiol Infect, 8, pp. 196-201
dc.descriptionLarsen, H., Nielsen, G.L., Sorensen, H.T., Moller, M., Olsen, J., Schonheyder, H.C., A follow-up study of birth outcome in users of pivampicillin during pregnancy (2000) Acta Obstet Gynecol Scand, 79, pp. 379-383
dc.descriptionCzeizel, A.E., Rockenbauer, M., Sorensen, H.T., Olsen, J., Teratogenic evaluation of oxacillin (1999) Scand J Infect Dis, 31, pp. 311-312
dc.descriptionAselton, P., Jick, H., Milunsky, A., Hunter, J.R., Stergachis, A., First-trimester drug use and congenital disorders (1985) Obstet Gynecol, 65, pp. 451-455
dc.descriptionJepsen, P., Skriver, M.V., Floyd, A., Lipworth, L., Schonheyder, H.C., Sorensen, H.T., A population-based study of maternal use of amoxicillin and pregnancy outcome in Denmark (2003) Br J Clin Pharmacol, 55, pp. 216-221
dc.descriptionCzeizel, A.E., Rockenbauer, M., Sorensen, H.T., Olsen, J., Augmentin treatment during pregnancy and the prevalence of congenital abnormalities: A population-based case-control teratologic study (2001) Eur J Obstet Gynecol Reprod Biol, 97, pp. 188-192
dc.descriptionShepherd, G.M., Hypersensitivity reactions to drugs: Evaluation and management (2003) Mt Sinai J Med, 70, pp. 113-125
dc.descriptionHeikkila, A., Erkkola, R., Review of beta-lactam antibiotics in pregnancy. The need for adjustment of dosage schedules (1994) Clin Pharmacokinet, 27, pp. 49-62
dc.descriptionEinarson, A., Shuhaiber, S., Koren, G., Effects of antibacterials on the unborn child: What is known and how should this influence prescribing (2001) Paediatr Drugs, 3, pp. 803-816
dc.descriptionCzeizel, A.E., Rockenbauer, M., Sorensen, H.T., Olsen, J., Use of cephalosporins during pregnancy and in the presence of congenital abnormalities: A population-based, case-control study (2001) Am J Obstet Gynecol, 184, pp. 1289-1296
dc.descriptionHeikkila, A., Renkonen, O.V., Erkkola, R., Pharmacokinetics and transplacental passage of imipenem during pregnancy (1992) Antimicrob Agents Chemother, 36, pp. 2652-2655
dc.descriptionBristol-Myers Squibb Company: Azactam®: Food and Drug Administration. 2004
dc.descriptionhttp://www.fda.gov/ cder/foi/label/2002/50580slr033lbl.pdf, searched May 2004Matsuda, S., Suzuki, M., Oh, K., Ishikawa, M., Soma, A., Takada, H., Shimizu, T., ChimuraT, Pharmacokinetic and clinical studies on imipenem/cilastatin sodium in the perinatal period. A study of imipenem/cilastatin sodium in the perinatal co-research group (1988) Jpn J Antibiot, 41, pp. 1731-1741
dc.descriptionGreenwood, D., Inhibitors of bacterial protein synthesis (1997) Antimicrobial chemotherapy, pp. 32-48. , Greenwood D ed, 3rd ed, Oxford University Press
dc.descriptionReyes, M.P., Ostrea Jr, E.M., Cabinian, A.E., Schmitt, C., Rintelmann, W., Vancomycin during pregnancy: Does it cause hearing loss or nephrotoxicity in the infant? (1989) Am J Obstet Gynecol, 161, pp. 977-981
dc.descriptionMensa, J., García-Vázquez, E., Vila, J., Macrólidos, cetólidos y estreptograminas (2003) Enferm lnfecc Microbiolo Cin, 21, pp. 200-208
dc.descriptionHedstrom, S., Martens, M.G., Antibiotics in pregnancy (1993) Clin Obstet Gynecol, 36, pp. 886-892
dc.descriptionLarsen, B., Glover, D.D., Serum erythromycin levels in pregnancy (1998) Clin Ther, 20, pp. 971-977
dc.descriptionCzeizel, A.E., Rockenbauer, M., Sorensen, H.T., Olsen, J., A population-based case-control teratologic study of oral erythromycin treatment during pregnancy (1999) Reprod Toxicol, 13, pp. 531-536
dc.descriptionLewis, J.H., Drug-induced liver disease (2000) Med Clin North Am, 84, pp. 1275-1311
dc.descriptionHonein, M.A., Paulozzi, L.J., Himelright, I.M., Lee, B., Cragan, J.D., Patterson, L., Correa, A., Erickson, J.D., Infantile hypertrophic pyloric stenosis after pertussis prophylaxis with erythromcyin: A case review and cohort study (1999) Lancet, 354, pp. 2101-2105
dc.descriptionLouik, C., Werler, M.M., Mitchell, A.A., Erythromycin use during pregnancy in relation to pyloric stenosis (2002) Am J Obstet Gynecol, 186, pp. 288-290
dc.descriptionSorensen, H.T., Skriver, M.V., Pedersen, L., Larsen, H., Ebbesen, F., Schonheyder, H.C., Risk of infantile hypertrophic pyloric stenosis after maternal postnatal use of macrolides (2003) Scand J Infect Dis, 35, pp. 104-106
dc.descriptionEinarson, A., Phillips, E., Mawji, F., D'Alimonte, D., Schick, B., Addis, A., Mastroiacova, P., Koren, G., A prospective controlled multicentre study of clarithromycin in pregnancy (1998) Am J Perinatal, 15, pp. 523-525
dc.descriptionFood and Drug Administration Revision - Biaxin® Granules - Abbott Laboratories
dc.description2000 http:// www.fda.gov/cder/foi/label/2000/50662S29lbl.pdf, searched May 2004Schonwald, S., Kuzman, I., Oreskovic, K., Burek, V., Skerk, V., Car, V., Bozinovic, D., Radosevic, S., Azithromycin: Single 1.5 g dose in the treatment of patients with atypical pneumonia syndrome - a randomized study (1999) Infection, 27, pp. 198-202
dc.descriptionBush, M.R., Rosa, C., Azithromycin and erythromycin in the treatment of cervical chlamydial infection during pregnancy (1994) Obstet Gynecol, 84, pp. 61-63
dc.descriptionPfizer Laboratories: Zithromax®. Food and Drug Administration
dc.description2003 http://www.fda.gov/cder/foi/label/ 2004/50670slr021,50693slr008,50730slr011_ zithromax_lbl.pdf, searched may, 2004Douthwaite, S., Hansen, L.H., Mauvais, P., Macrolide-ketolide inhibition of MLS-resistant ribosomes is improved by alternative drug interaction with domain Il of 23S rRNA (2000) Mol Microbiol, 36, pp. 183-193
dc.descriptionJamjian, C., Biedenbach, D.J., Jones, R.N., In vitro evaluation of a novel ketolide antimicrobial agent, RU-64004 (1997) Antimicrob Agents Chemother, 41, pp. 454-459
dc.descriptionAventis Pharmaceutical Inc. KETEK™ - Telithromycin. Food and Drug Administration
dc.description2004. http:// www.fda.gov/cder/foi/label/2004/21144_ketekj bl.pdf, searched may, 2004Philipson, A., Sabath, L.D., Charles, D., Transplacental passage of erythromycin and clindamycin (1973) N Engl J Med, 288, pp. 1219-1221
dc.descriptionWeinstein, A.J., Gibbs, R.S., Gallagher, M., Placental transfer of clindamycin and gentamicin in term pregnancy (1976) Am J Obstet Gynecol, 124, pp. 688-691
dc.descriptionMickal, A., Panzer, J.D., The safety of lincomycin in pregnancy (1975) Am J Obstet Gynecol, 121, pp. 1071-1074
dc.descriptionCzeizel, A.E., Rockenbauer, M., Olsen, J., Sorensen, H.T., A teratological study of aminoglycoside antibiotic treatment during pregnancy (2000) Scand J Infect Dis, 32, pp. 309-313
dc.descriptionChan, K.W., WL, N., Gentamicin nephropathy in a neonate (1985) Pathology, 17, pp. 514-515
dc.descriptionConway, N., Birt, B.D., Streptomycin in pregnancy: Effect on the foetal ear (1965) Br Med J, 31, pp. 260-263
dc.descriptionDonald, P.R., Sellars, S.L., Streptomycin ototoxicity in the unborn child (1981) S Afr Med J, 22, pp. 316-318
dc.descriptionMarynowski, A., Sianozecka, E., Comparison of the incidence of congenital malformations in neonates from healthy mothers and from patients treated because of tuberculosis (1972) Ginekol Pol, 43, pp. 713-715
dc.descriptionMurphy, J.F., Drugs and pregnancy (1984) Ir Med J, 77, pp. 52-56
dc.descriptionChambers HS Antimicrobial Agents: Protein Synthesis Inhibitors and Miscellaneous Antibacterial Agents. In: Hardman JG, Gilman AG, Limbird LE (ed.) Goodman & Gilman's The Pharmacological Basis of Therapeutics, 1996, McGraw-Hill, 1239-1272Czeizel, A.E., Rockenbauer, M., A population-based case-control teratologic study of oral Oxytetracycline treatment during pregnancy (2000) Eur J Obstet Gynecol Reprod Biol, 88, pp. 27-33
dc.descriptionHautekeete, M.L., Hepatotoxicity of antibiotics (1995) Acta Gastroenterol Belg, 58, pp. 290-296
dc.descriptionOnur MA, Vural I, Kas HS, Hincal AA, Coskun T, Kanra G, Turner A. Decrease in the placental transfer of chloramphenicol when administered in albumin microspheres into rats. J Microencapsul. 1993
dc.description10: 367-374Johnson, T.N., The development of drug metabolising enzymes and their influence on the susceptibility to adverse drug reactions in children (2003) Toxicology, 92, pp. 37-48
dc.descriptionKnight, M., Adverse drug reactions in neonates (1994) J Clin Pharmacol, 34, pp. 128-135
dc.descriptionSorensen, H.T., Larsen, H., Jensen, E.S., Thulstrup, A.M., Schonheyder, H.C., Nielsen, G.L., Czeizel, A., Safety of metronidazole during pregnancy: A cohort study of risk of congenital abnormalities, preterm delivery and low birth weight in 124 women (1999) J Antimicrob Chemother, 44, pp. 854-856
dc.descriptionRodin, P., Hass, G., Metronidazole and pregnancy (1966) Br J Vener Dis, 42, pp. 210-212
dc.descriptionPiper, J.M., Mitchel, E.F., Ray, W.A., Prenatal use of metronidazole and birth defects: No association (1993) Obstet Gynecol, 82, pp. 348-352
dc.descriptionBeard, C.M., Noller, K.L., O'Fallon, W.M., Kurland, L.T., Dahlin, D.C., Cancer after exposure to metronidazole (1988) Mayo Clin Proc, 63, pp. 147-153
dc.descriptionSaravanos, K., Duff, P., The quinolone antibiotics (1992) Obstet Gynecol Clin North Am, 19, pp. 529-537
dc.descriptionLoebstein, R., Addis, A., Ho, E., Andreou, R., Sage, S., Donnenfeld, A.E., Schick, B., Koren, G., Pregnancy outcome following gestational exposure to fluoroquinolones: A multicenter prospective controlled study (1998) Antimicrob Agents Chemother, 42, pp. 1336-1339
dc.descriptionHooton, T.M., Stamm, W.E., Diagnosis and treatment of uncomplicated urinary tract infection (1997) Infect Dis Clin North Am, 11, pp. 551-581
dc.descriptionGrady R Safety profile of quinolone antibiotics in the pediatric population. Pediatr Infect Dis J. 2003
dc.description22: 1128-1132Yabe, K., Yoshida, K., Yamamoto, N., Nishida, S., Ohshima, C., Sekiguchi, M., Yamada, K., Furuhama, K., Diagnosis of quinolone-induced arthropathy in juvenile dogs by use of magnetic resonance (MR) imaging (1997) J Vet Med Sci, 59, pp. 597-599
dc.descriptionNagai, A., Miyazaki, M., Morita, T., Furubo, S., Kizawa, K., Fukumoto, H., Sanzen, T., Kawamura, Y., Comparative articular toxicity of garenoxacin, a novel quinolone antimicrobial agent, in juvenile beagle dogs (2002) J Toxicol Sci, 27, pp. 219-228
dc.descriptionBerkovitch, M., Pastuszak, A., Gazarian, M., Lewis, M., Koren, G., Safety of the new quinolones in pregnancy (1994) Obstet Gynecol, 84, pp. 535-538
dc.descriptionDanisovicova, A., Brezina, M., Belan, S., Kayserova, H., Kaiserova, E., Hruskovic, I., Orosova, K., Matheova, E., Magnetic resonance imaging in children receiving quinolones: No evidence of quinolone-induced arthropathy. A multicenter survey (1994) Chemotherapy, 40, pp. 209-214
dc.descriptionReid, D.W., Caille, G., Kaufmann, N.R., Maternal and transplacental kinetics of trimethoprim and sulfamethoxazole, separately and in combination (1975) Can Med Assoc J, 14, pp. 67-72
dc.descriptionCzeizel, A.E., Rockenbauer, M., Sorensen, H.T., Olsen, J., The teratogenic risk of trimethoprim-sulfonamides: A population based case-control study (2001) Reprod Toxicol, 15, pp. 637-646
dc.descriptionAhlfors, C.E., Unbound bilirubin associated with kernicterus: A historical approach (2000) J Pediatr, 137, pp. 540-544
dc.descriptionPerkins, R.P., Hydrops fetalis and stillbirth in a male glucose-6-phosphate dehydrogenase-deficient fetus possibly due to maternal ingestion of sulfisoxazole
dc.descriptiona case report (1971) Am J Obstet Gynecol, 111, pp. 379-381
dc.descriptionHernandez-Diaz, S., Werler, M.M., Walker, A.M., Mitchell, A.A., Folic acid antagonists during pregnancy and the risk of birth defects (2000) N Engl J Med, 343 (30), pp. 1608-1614
dc.languagept
dc.publisher
dc.relationRevista Brasileira de Medicina
dc.rightsfechado
dc.sourceScopus
dc.titleAntimicrobial Therapy During Pregnancy [terapêutica Antimicrobiana Durante A Gestação]
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución